Clinical Study
Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study
Figure 1
Classification of CD155 expression on BC tissues. (a) Overexpression of CD155. (b) Low expression of CD155.
(a) |
(b) |